Gonorrhea Therapeutics Market Share

Statistics for the 2023 & 2024 Gonorrhea Therapeutics market share, created by Mordor Intelligence™ Industry Reports. Gonorrhea Therapeutics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Gonorrhea Therapeutics Industry

The market for gonorrhea therapeutics is fragmented in terms of competition, despite the presence of major pharmaceutical companies. Some of the major players in the gonorrhea therapeutics market include AbbVie (Allergan, Inc.), F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Lupin Pharmaceuticals, Pfizer Inc., Teligent, Inc., Merck & Co., Inc., Hologic, Inc., Danaher Corporation, Becton Dickinson and Company, and AstraZeneca.

Gonorrhea Therapeutics Market Leaders

  1. Allergan, Inc.

  2. F. Hoffmann-La Roche Ltd

  3. GlaxoSmithKline plc

  4. Lupin Pharmaceuticals, Inc.

  5. Pfizer Inc.

*Disclaimer: Major Players sorted in no particular order

Gonorrhea Therapeutics Market.png

Gonorrhea Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)